Ebixa is also available as an oral solution, which is supplied with a pump that delivers 5 mg memantine hydrochloride with each activation. What is Ebixa used for? Ebixa is used to treat …

Ebixa: Ebixa, brand name of Memantine, is a NMDA receptor antagonist medication used to treat people with moderate-to-severe Alzheimer's disease

2025年1月7日 · In order to lower the risk of side effects, the dose should be achieved by upward titration with 5 mg per week over 3 weeks, achieving the maintenance dose of 20 mg/day from …

为了减少不良反应的发生,在治疗的前3周应按每周递增5mg剂量的方法逐渐达到维持剂量,具体如下: 治疗第一周的剂量为每日5mg ,每日一次, 第二周每日10mg,每日一次, 第三周每日15mg ,每日 …

2021年12月13日 · Ebixa should be taken orally once daily at the same time each day. The solution can be taken with or without food. The solution must not be poured or pumped into the …

Ebixa is a medicine that contains the active substance memantine hydrochloride. It is available as tablets (5 mg, 10 mg, 15 mg and 20 mg). Ebixa is also available as an oral solution, which is …

2025年1月18日 · Memantine helps to ease the symptoms of dementia in Alzheimer's disease. Take one dose every day, at the same time of day each day. You can take memantine either …

2016年7月8日 · Ebixa® belongs to a group of medicines called NMDA-receptor antagonists. The action of Ebixa® on NMDA-receptors may help normalize the transmission of nerve signals, …

2016年7月8日 · Ebixa , treatment was initiated at 5 mg/day and increased weekly by 5 mg/day to a dose of 20 mg/day (10 mg twice a day). Study Outcome Measures: In each study, the …

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.